Oligomer-containing substituted aromatic triazine compounds
View Patent ↗The invention relates to (among other things) methods for treatment comprising administering oligomer-containing substituted aromatic triazine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
1. A compound encompassed by the following formula:
or a pharmaceutically acceptable salt thereof, wherein:
R 1 is selected from the group consisting of Cl, Br, I, C 1-4 alkyl and OMe;
R 2 is selected from the group consisting of Cl, Br, I, C 1-4 alkyl and OMe; and
n is an integer selected from the group consisting of 2, 3, 4, 5, 6, 7, 8, 9, 10 and 11.
2. The compound of claim 1 , wherein: R 1 is selected from the group consisting of Cl, Br, I, and C 1-4 alkyl; and R 2 is selected from the group consisting of Cl, Br, I, and C 1-4 alkyl.
3. The compound of claim 1 , wherein: R 1 is selected from the group consisting of Cl, Br and I; and R 2 is selected from the group consisting of Cl, Br and I.
4. The compound of claim 1 , wherein R 1 is Cl and R 2 is Cl.
5. The compound of claim 4 , wherein n is selected from the group consisting of 2, 3, 4, 5 and 6.
6. The compound of claim 5 , wherein n is 2.
7. The compound of claim 5 , wherein n is 3.
8. The compound of claim 5 , wherein n is 4.
9. The compound of claim 5 , wherein n is 5.
10. The compound of claim 1 , wherein n is selected from the group consisting of 2, 3, 4, 5 and 6.
11. The compound of claim 1 , wherein n is 2.
12. The compound of claim 1 , wherein n is 3.
13. The compound of claim 1 , wherein n is 4.
14. The compound of claim 1 , wherein n is 5.